Iq-ai Share Discussion Threads

[lr2] 06/6/2019 13:38

Aw, you do like me after all HH, copying my links from earlier in the day. Now go and find, if you can, what Trevor Brown has told Feedback shareholders regarding the viability of TexRAD. Better still, phone him and get it straight from the horse's mouth.

[hedgehog 100] 06/6/2019 13:32

"AI Has Great Potential To Enable Better Cancer Care-Dr Balaji Ganeshan

By EH News Bureau On Jun 6, 2019

Using AI to analyse tumours and uncover biomarkers Radiomics is an area of medical study that aims to extract large amounts of quantitative features from medical images using algorithms to analyse and characterise data. Using new technologies and artificial intelligence (AI), this field is undergoing rapid change as the potential to uncover disease characteristics (biomarkers) that traditional analysis of scans are often unable to identify, is being developed. When a radiologist looks at the image of a tumour on a CT or MRI scan they can see the shape, outline and position of the cancer, while the computer creating the image sees a large number of individual pixels, each with a different density. New algorithms and AI are being developed which can use this data to analyse tumours on a region by region basis, generating more information for the clinician to help them understand the nature of the disease.

One of these tools, TexRAD is an algorithm used as a research tool by more than 60 prolific university hospitals and imaging centres across the world to compare patterns of pixel density to produce information on the texture of the tissue. The system uncovers potential radiological biomarkers in medical images that are typically not visible to the naked eye, providing significant additional information which may assist discussions about treatment regimes. As tissue structure is altered by disease, especially by cancer, biomarkers which reliably measure this could be extremely valuable. ..."

[hazl] 06/6/2019 13:22

' Imaging Biometrics

IB provides advanced imaging software used by cancer hospitals and universities in the US such as the Mayo Clinic and Stanford University Medical Centre. One application it is commercialising aids in the detection and staging of chronic liver disease, while another “leverages deep learning algorithms” for breast cancer screening.
Developments and new products

Fee per click service to make IB's products more economically accessible and to promote immediate widespread distribution
IB Server is an application that provides immediate access to the company’s clinically-validated processing algorithms
Artificial intelligence is being used to enhance and automate software
PC-based version of IB plugins so the software is available on Microsoft Windows platforms and not just Apple computers
Gadolinium-free imaging. IB has a patent for an image processing technology that doesn’t use the possibly toxic rare earth
'

[hedgehog 100] 06/6/2019 13:18

"Nearly three quarters of a million patients set to benefit from world-leading innovations on the NHS

5 June 2019

3D heart modelling to rapidly diagnose coronary disease and an advanced blood test which can cut the time it takes to rule-out a heart attack by 75% are among a raft of technological innovations being introduced for patients across the NHS.

New innovations have already reached 300,000 patients, and speaking at the Reform digital health conference in London today, NHS England chief executive Simon Stevens will announce that over 400,000 more will benefit this year from new tests, procedures and treatments as part of the Long Term Plan. ..."

[hazl] 06/6/2019 13:12

'Trevor Brown told investors he expects sales to double year on year: “Our objectives for 2019 are to expand sales and continue to develop new products which utilise areas of our expertise where we believe we have scientific and technological leadership. As a result of product development and new users, sales have continued to accelerate in 2019.The future looks to be an exciting place for IQ-AI.”

[hazl] 06/6/2019 13:11

IQ-AI becoming a leader in the field of medical imaging diagnostics
11:06 24 May 2019

[hedgehog 100] 06/6/2019 13:09

"NHS aims to be a world leader in artificial intelligence and machine learning within 5 years

5 June 2019

NHS chief Simon Stevens today called on tech firms to help the health service become a world leader in the use of artificial intelligence (AI) and machine learning.

He also asked staff to work with us and share ideas on reforms to the payment systems that would help encourage and facilitate quicker adoption and expansion.

The technology can help speed up diagnosis of cancer and other diseases and deliver more convenient care by revolutionising outpatient services. ...

Exploiting the boom in AI technology will help to meet the NHS Long Term Plan’s target of making up to 30 million outpatient appointments unnecessary, saving over £1 billion in what would have been increasing outpatient visits which can then be reinvested in front line care, saving patients unnecessary journeys to hospitals.

Simon Stevens, NHS chief executive, said: “As part of the NHS Long Term Plan we are going to be using new technologies and treatments to improve patient care and save more lives.

“We are seeing an artificial intelligence revolution that will be a big part of our future over the next five years, with technologies that can cut the time patients wait for scan results and ease the burden on hard working staff. ...

There were 315,000 MRI scans and over 520,000 CT scans in March alone, according to the latest figures. That is up 20% from 260,000 MRI in the same month three years ago and CT scans were up a third from 390,000 CT.

According to Royal College of Radiologists, in mammography screening the NHS is performing around two million breast screens for women a year in the UK, with each test result reviewed by two clinicians.

Testing of AI and machine learning technology has already demonstrated its potential to ease the burden on staff and free them up for other work. ..."

[hazl] 06/6/2019 13:08

thanks to LR2 So pleased to see they are cheered up at last.

[hedgehog 100] 06/6/2019 12:15

06/06/2019 11:49 UKREG IQ-AI Limited Result of AGM
"IQ-AI Limited announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed."

[hazl] 06/6/2019 10:13

Well FDBK has had a lift from an article on NHS tech in Times today....lets hope it transfers over here as well.

[hazl] 06/6/2019 07:46

Thanks H....coming up to an exciting time hopefully!

[hedgehog 100] 05/6/2019 17:03

A good Proactive Investors IQAI article from twelve days ago, that hasn't been featured on this thread before:

"IQ-AI becoming a leader in the field of medical imaging diagnostics

11:06 24 May 2019

Here we take a closer look at the imaging and diagnostics firm IQ-AI Limited (LON:IQAI)

• Two businesses, one vision
• Strong development pipeline
• Expects sales to double this year

IQ-AI is the company formerly known as Flying Brands. The name reflects its aspiration of becoming a leader in the field of medical imaging diagnostics. It currently comprises of two businesses - Stone Checker Software and Imaging Biometrics (IB).

StoneChecker

This is predictive diagnostic software product that helps urologists determine whether a kidney stone will disintegrate under a vibration process called lithotripsy. This capability becomes important in determining whether to subject patients to multiple rounds of lithotripsy or send them straight to surgery. Its products are now sold in the USA, UK, The Netherlands, Switzerland, Germany, Greece and South Korea.

Imaging Biometrics

IB provides advanced imaging software used by cancer hospitals and universities in the US such as the Mayo Clinic and Stanford University Medical Centre. One application it is commercialising aids in the detection and staging of chronic liver disease, while another “leverages deep learning algorithms” for breast cancer screening.

Developments and new products

•Fee per click service to make IB's products more economically accessible and to promote immediate widespread distribution
• Server is an application that provides immediate access to the company’s clinically-validated processing algorithms
•Artificial intelligence is being used to enhance and automate software
•PC-based version of IB plugins so the software is available on Microsoft Windows platforms and not just Apple computers
•Gadolinium-free imaging. IB has a patent for an image processing technology that doesn’t use the possibly toxic rare earth

Outlook

On April 30 chief executive Trevor Brown told investors he expects sales to double year on year: “Our objectives for 2019 are to expand sales and continue to develop new products which utilise areas of our expertise where we believe we have scientific and technological leadership. As a result of product development and new users, sales have continued to accelerate in 2019.The future looks to be an exciting place for IQ-AI.” "

[hedgehog 100] 04/6/2019 14:30

For greater perspective, it's also useful to look at the longer term charts before the name change to IQAI last year, i.e. for FBDU (Flying Brands).

This shows the significance of volume increase for rapid multibagging.

And it also shows that the long term support level is just above a penny ... so at its current 1.3p IQAI is starting to build up a rise from this.

[hedgehog 100] 04/6/2019 14:14

Hazl,

The increase in trading volumes recently should also be viewed positively, according to ADVFN charting guru Melfarj.

From the thread "Faraj List of Exploding Stocks 9.10" -

melfaraj 18 May '14 - 10:58 - 1887 of 30518
" ... for very small companies technical analysis is not of great value, except for one indicator, volume which has been rising impressively at an increased rates since last year. ... "

[hazl] 04/6/2019 09:06

A bit of blue on a down day bodes well.

[hazl] 03/6/2019 18:39

Thanks indeed hedgehog.

[hazl] 03/6/2019 09:56

Just to clarify....it is completely the FDA 's decision of course when the approval.... if it happens will be announced.
People on a different discussion thread are implying it might not be June.
I guess they are a law unto themselves.

[hazl] 01/6/2019 18:28

From memory June has been mentioned for some sort of decision for Stonechecker but that is completely out of IQAI's hands.
'
Can we NOT make this board about 'one-up manship' between two posters please?
LR you know you are trying to cause trouble.

Just think for a moment about those poor people who have medical problems that might be aided by stone checker....the only one as far as I know that hasn't the nasty ingredient in it....(Gadolinium free)
Would they want you to trivialise the whole process by having to win some kind of ridiculous argument?
Grow up please!

[lr2] 01/6/2019 16:57

I see the revenue for the last financial year was reported as £164,971 and all of that came from Imaging Biometrics according to Note 10 in the year end report.

"The revenue included in the consolidated income statement since 13 March 2018 contributed by Imaging Biometrics was £164,971. Imaging Biometrics also reported a loss of £165,291 over the same period."

So, no revenue accrued from Stone Checker that year.

Do you have any idea when the FDA approval for Stone Checker might arrive so that it can be sold Stateside? I'm assuming TB hasn't given a recent update on this. Q1 '19 was the last date I was aware of and we are now only 4 weeks away from Q3.

[lr2] 01/6/2019 16:37

HH, I've got news for you. I don't read most of your posts. Especially the long 'cut and paste' ones like #186. I find them tedious and a waste of my time. However, I've just gone back to your post and see that I was incorrect in this one instance so I will correct my original post and hopefully put a smile on your face.

LR 4 - TB&HH 1